Feb 6 (Reuters) - Commonwealth Bank of Australia (CBA) said on Monday it will simplify its financial reporting in upcoming half-year fiscal results to reflect the sale of its wealth management business last year.
The country's top lender will now consolidate its other banking income, funds management income and insurance income into other operating income within its financial statements to reflect the divestment.
The change has been applied retrospectively, resulting in a reduction of A$109 million ($75.12 million) in operating expenses for half-year ended June 2022, and reduction of A$98 million in other operating income for half-year ended December 2021.
CBA will announce its first-half results for fiscal 2023 on February 15, 2023.
($1 = 1.4510 Australian dollars) (([email protected]; Twitter: https://twitter.com/sameer_manekar;))
- Forums
- ASX - By Stock
- CBA
- News: CBA Australia's CBA simplifies financial reporting after sale of wealth management unit
CBA
commonwealth bank of australia.
Add to My Watchlist
2.81%
!
$185.36

News: CBA Australia's CBA simplifies financial reporting after sale of wealth management unit
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$185.36 |
Change
-5.350(2.81%) |
Mkt cap ! $310.1B |
Open | High | Low | Value | Volume |
$190.50 | $191.06 | $185.36 | $367.6M | 1.971M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4521 | $185.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$185.88 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 185.360 |
18 | 4516 | 185.000 |
1 | 50 | 184.950 |
4 | 383 | 184.500 |
1 | 15 | 184.400 |
Price($) | Vol. | No. |
---|---|---|
185.880 | 70 | 1 |
186.090 | 50 | 1 |
187.000 | 300 | 1 |
187.400 | 5 | 1 |
187.600 | 58 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CBA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online